HKG Equity Snapshot

2659 Weekly Equity Report

Shanghai Bao Pharmaceuticals Co., Ltd.

Interactive chart JSON snapshot
Latest Close 19.32 HKD 12 Jun 2026
1W Return -10.6% latest completed week
4W Return -23.0% short-term follow-through
12W Return -79.4% quarterly tape
Trend Breadth 0.0% 0 of 27 weeks active
Volume Ratio 0.6x vs 13-week average
Company Brief

What the company does

Shanghai Bao Pharmaceuticals Co., Ltd., a biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs. Its products include KJ017, a recombinant human hyaluronidase for subcutaneous drug delivery; KJ103, a recombinant immunoglobulin G (IgG)-degrading enzyme for IgG-mediated autoimmune diseases; and SJ02, a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH CTP) for assisted reproduction. The company also develops KJ101, a recombinant human chymotrypsin developed through synthetic biology that is in Phase 2 clinical trials; KJ015, …

Snapshot

What the weekly tape is saying

2659 closed the latest completed week at 19.32 HKD. The 4-week return is -23.0% and the 12-week return is -79.4%. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -
Volume 0.6x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 50 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 26 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
-
Vs Trend Line
-
Fair Value
81.93 HKD
Vs Fair Value
-76.4%
52W High
206.0 HKD
52W Low
18.25 HKD
Drawdown
-90.6%
Range Position
0.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -10.6%
4W -23.0%
12W -79.4%
26W -71.7%
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
HK Healthcare
Sector Rank
238 of 257
Sector Percentile
7.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.00
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Negative
Probability
42.18%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
9.8M
13W Average
15.9M
52W Average
9.4M
Vs 13W
0.6x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
18.3%
52W Volatility
20.2%
Upside Weeks
11
Downside Weeks
15
Downside Breadth
57.7%
Avg Gain / Loss
13.4% / -13.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
7.5B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.

Watch next

  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 19.32 HKD -10.6% - 81.93 HKD 0.00 - 9.8M Off
5 Jun 2026 21.60 HKD -12.0% - 84.33 HKD 0.00 - 17.1M Off
29 May 2026 24.54 HKD 0.1% - 86.84 HKD 0.00 - 11.5M Off
22 May 2026 24.52 HKD -2.3% - 89.44 HKD 0.00 - 37.3M Off
15 May 2026 25.10 HKD -8.4% - 92.26 HKD 0.00 - 41.3M Off
8 May 2026 27.40 HKD 6.2% - 95.32 HKD 0.00 - 40.4M Off
1 May 2026 25.80 HKD -66.9% - 98.55 HKD 0.00 - 32.7M Off
24 Apr 2026 77.85 HKD -13.2% - 102.2 HKD 0.00 - 2.9M Off
17 Apr 2026 89.65 HKD -9.9% - 103.5 HKD 0.00 - 1.7M Off
10 Apr 2026 99.55 HKD -3.2% - 104.2 HKD 0.00 - 3.5M Off
3 Apr 2026 102.8 HKD 14.5% - 104.5 HKD 0.00 - 3.0M Off
27 Mar 2026 89.80 HKD -4.1% - 104.6 HKD 0.00 - 2.9M Off
20 Mar 2026 93.65 HKD -7.3% - 105.6 HKD 0.00 - 2.6M Off
13 Mar 2026 101.0 HKD -0.4% - 106.5 HKD 0.00 - 5.7M Off